SG11201502108RA - Methods for treating hepatitis c - Google Patents

Methods for treating hepatitis c

Info

Publication number
SG11201502108RA
SG11201502108RA SG11201502108RA SG11201502108RA SG11201502108RA SG 11201502108R A SG11201502108R A SG 11201502108RA SG 11201502108R A SG11201502108R A SG 11201502108RA SG 11201502108R A SG11201502108R A SG 11201502108RA SG 11201502108R A SG11201502108R A SG 11201502108RA
Authority
SG
Singapore
Prior art keywords
methods
treating hepatitis
hepatitis
treating
Prior art date
Application number
SG11201502108RA
Other languages
English (en)
Inventor
Tami J Pilot-Matias
Preethi Krishnan
Warren M Kati
Christine A Collins
Neeta C Mistry
Clarence J Maring
David A Degoey
John K Pratt
Dachun Liu
Rolf Wagner
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc filed Critical Abbvie Inc
Publication of SG11201502108RA publication Critical patent/SG11201502108RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201502108RA 2012-09-18 2013-09-17 Methods for treating hepatitis c SG11201502108RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261702569P 2012-09-18 2012-09-18
PCT/US2013/060122 WO2014047048A1 (en) 2012-09-18 2013-09-17 Methods for treating hepatitis c

Publications (1)

Publication Number Publication Date
SG11201502108RA true SG11201502108RA (en) 2015-05-28

Family

ID=49304328

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201502108RA SG11201502108RA (en) 2012-09-18 2013-09-17 Methods for treating hepatitis c

Country Status (14)

Country Link
US (1) US20140080886A1 (zh)
EP (1) EP2897609A1 (zh)
JP (1) JP2015528513A (zh)
CN (1) CN104780920A (zh)
AU (1) AU2013318311A1 (zh)
BR (1) BR112015006058A2 (zh)
CA (1) CA2885024A1 (zh)
HK (1) HK1209320A1 (zh)
MX (1) MX2015003500A (zh)
RU (1) RU2015114566A (zh)
SG (1) SG11201502108RA (zh)
TW (1) TW201412309A (zh)
WO (1) WO2014047048A1 (zh)
ZA (1) ZA201501758B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10201584B1 (en) * 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US20150141351A1 (en) * 2013-11-18 2015-05-21 AbbVie Deutschland GmbH & Co. KG Solid Pharmaceutical Compositions
WO2017189978A1 (en) 2016-04-28 2017-11-02 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
CN116887866A (zh) 2020-12-03 2023-10-13 巴特尔纪念研究院 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
CN113862231B (zh) * 2021-10-08 2024-02-13 中山大学 一种3a型丙肝病毒亚基因组复制子及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2455376T3 (en) * 2009-06-11 2015-03-02 Abbvie Bahamas Ltd Heterocyclic compounds as inhibitors of hepatitis C virus (HCV)
ES2527544T1 (es) * 2011-10-21 2015-01-26 Abbvie Inc. Tratamiento mono (PSI-7977) o de combinación con AAD para su uso en el tratamiento del VHC

Also Published As

Publication number Publication date
BR112015006058A2 (pt) 2017-07-04
WO2014047048A1 (en) 2014-03-27
ZA201501758B (en) 2016-01-27
MX2015003500A (es) 2015-06-22
EP2897609A1 (en) 2015-07-29
AU2013318311A1 (en) 2015-04-02
US20140080886A1 (en) 2014-03-20
CA2885024A1 (en) 2014-03-27
HK1209320A1 (zh) 2016-04-01
RU2015114566A (ru) 2016-11-10
TW201412309A (zh) 2014-04-01
JP2015528513A (ja) 2015-09-28
CN104780920A (zh) 2015-07-15

Similar Documents

Publication Publication Date Title
HRP20180237T1 (hr) Metode za liječenje hcv-a
HK1214504A1 (zh) 用於治療貧血的方法
HK1209745A1 (zh) 用於抗病毒治療的化合物和方法
HK1209319A1 (zh) 用於治療丙型肝炎的方法
EP2757887A4 (en) PYRROLOPYRIDINONE COMPOUNDS AND METHOD FOR THE TREATMENT OF HIV
HK1198869A1 (zh) 丙型肝炎的聯合治療
ZA201906339B (en) Methods for treating pruritus
HK1209320A1 (zh) 用於治療丙型肝炎的方法
ZA201406172B (en) Compounds and methods for treating leukemia
HK1209040A1 (zh) 用於治療前庭毒性的方法
EP2854774A4 (en) METHODS OF TREATING INSOMNIA
GB201214387D0 (en) Methods for treating plants
GB201209932D0 (en) Improved process